The genomics research team is engaged in several research studies that pursue to improve patients outcomes and over-all survival rates. A recent study was carried out on klebsiella pneumonia, which is a bacteria known to be one of the most common species related to hospital acquired infections.
According to Dr. Aya Deyab, one of the researchers, this bacteria is responsible for several human infections including urinary tract, respiratory tract, and bloodstream infections in addition to its resistance to most known antibiotics which makes it life threatening specially for our immunocompromised cancer patients.
This research, published in PLOS One journal (impact factor 3.24), contributes to improving patient outcome as it makes recommendations for the medical team to avoid antibiotics resisted by the bacteria as it will not be useful for the patient. At the Children’s Cancer Hospital Egypt 57357, researchers are equipped with cutting-edge technologies that help us dig deep into the composition of the genes of the bacteria to understand and identify the changes that led to the development of resistance to antibiotics. Thanks to bioinformatics and high computational power we are provided with in our lab in 57357, we are capable of decoding the genetics of the bacteria and what made them acquire the resistance.
This paper, plays an important role in understanding the resistance and genetic composition of Klebsiella pneumonia in hospitalized patients that causes poor clinical outcome and is a present danger. This can help us understand how the resistance work which would ultimately enable us to protect our children from bacterial infections, providing them a safer environment and increasing the over-all survival rate.